• Skip to primary navigation
  • Skip to main content
  • Skip to footer
Home
  • LinkedIn
  • Twitter

  • About Us
    • Overview
    • Executive Committee
    • Board Of Directors
    • Partners
  • Science
    • Overview
    • Approach
    • Technology
      • Our Technology
      • TIM
      • shRNA
      • shARC Platform
    • Scientific Publications
  • Pipeline
  • Newsroom
    • Press Releases
    • Events
    • Media Center
  • Investors
    • Overview
    • Analyst Coverage
    • Corporate Governance
    • Regulated Information
    • Shareholders Information
    • Shareholders Meeting
  • Careers
  • Contact Us

Celyad Announces February and March 2019 Investor Conference Schedule

February 21, 2019 By Celyad

Mont-Saint-Guibert, Belgium – Celyad (Euronext Brussels and Paris, and Nasdaq: CYAD), a clinical-stage biopharmaceutical company focused on the development of CAR-T cell-based therapies, today announced that management plans to present at four investor conferences in February and March 2019.


Conference details:

8th Annual SVB Leerink Global Healthcare Conference

Date: Thursday, February 28, 2019

Presentation time: 1:30 p.m. ET

Location: New York, NY

A live webcast of the presentation can be accessed here.

Cowen 39th Annual Health Care Conference

Date: Monday, March 11, 2019

Presentation Time: 3:30 p.m. ET

Location: Boston, MA

A live webcast of the presentation can be accessed here. 

BioCapital Europe 2019*

Date: Thursday, March 14, 2019

Presentation Time: 3:20 p.m. CET

Location: Amsterdam

William Blair 9th Annual Cancer Immunotherapy Conference*

Date: Wednesday, March 20, 2019

Presentation Time: 10:30 a.m. ET

Location: New York, NY

An archived recording of the webcasts noted above will also be available under Events & Webcasts in the Investors section of the Company’s website.


[*] This event will not be webcast.

Download press release(s)
Communiqué de presse
Press Release
Persbericht

Filed Under: Corporate, Non-regulated

Footer

Celyad Oncology

Celyad Oncology Logo
  • About
  • Science
  • Pipeline
  • Newsroom
  • Investors
  • Contact Us
  • LinkedIn
  • Twitter

Copyright © 2020 All Rights Reserved.

  • Cookie Policy |
  • Privacy Policy |
  • Terms of Use